Institutional members access full text with Ovid®

Share this article on:

Reply to Letter: “Tumor Regression After Neoadjuvant Chemotherapy in Gastric Carcinoma Are There Really So Few Responders?”

Langer, Rupert MD; Reim, Daniel MD; Höfler, Heinz MD; Becker, Karen MD

doi: 10.1097/SLA.0000000000000280
e-Letters to the Editor: Response to Letter

Institute of Pathology University of Bern Murtenstr. 31 CH 3010 Bern

Department of Surgery, Klinikum Rechts der Isar, Technische Universität München Munich, Germany

Institute of Pathology, Technische Universität München Munich, Germany

Disclosure: On behalf of all authors (Rupert Langer, Daniel Reim, Heinz, Hofler, Karen Becker) I hereby declare that there is no conflict of interest. No author has received relevant honoraria, which would cause a conflict of interest.

(By Stefano Rausei et al., commenting on: Becker K, Langer R, Reim D, et al. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Ann Surg 2011;253:934-939).

© 2014 by Lippincott Williams & Wilkins.